Filgotinib per al tractament de l’artritis reumatoide
Filgotinib; Rheumatoid arthritis; Janus ...
openaire +1 more source
Filgotinib in Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis of Efficacy and Adverse Events. [PDF]
Khoshaim YA +11 more
europepmc +1 more source
Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc +1 more source
Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy. [PDF]
Wang J +5 more
europepmc +1 more source
Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry. [PDF]
Sonomoto K +9 more
europepmc +1 more source
Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]
Ahsan MU +5 more
europepmc +1 more source
Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials. [PDF]
Mirghani Idris RG +6 more
europepmc +1 more source
Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study. [PDF]
Itoi Y +16 more
europepmc +1 more source
Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib. [PDF]
Pruijt MJ +7 more
europepmc +1 more source
Background. To evaluate safety of filgotinib in terms of frequency, severity, and type of adverse events (AEs) and to identify predictors of AEs in a multicentre cohort of patients with rheumatoid arthritis (RA). Materials and Methods.
Società Italiana di Reumatologia
doaj

